These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8459037

  • 21. Growth fractions in bladder cancer defined by Ki67: association with cancer grade, category and recurrence rate of superficial lesions.
    Stavropoulos NE, Ioackim-Velogianni E, Hastazeris K, Kitsiou E, Stefanaki S, Agnantis N.
    Br J Urol; 1993 Nov; 72(5 Pt 2):736-9. PubMed ID: 8281405
    [Abstract] [Full Text] [Related]

  • 22. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index.
    Wright C, Thomas D, Mellon K, Neal DE, Horne CH.
    Br J Urol; 1995 Feb; 75(2):173-9. PubMed ID: 7850321
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.
    Tinnemans MM, Lenders MH, ten Velde GP, Wagenaar SS, Blijham GH, Ramaekers FC, Schutte B.
    Virchows Arch; 1995 Feb; 427(3):295-301. PubMed ID: 7496600
    [Abstract] [Full Text] [Related]

  • 24. [Ag-NORs, nucleus-nucleolus-associated antigens (Ki67, PCNA, P-105 and p-120): prognostic markers of meningioma recurrence].
    Crafa P, Campanini N, Martella EM, Trabattoni G, Tedeschi F.
    Acta Biomed Ateneo Parmense; 1994 Feb; 65(5-6):297-308. PubMed ID: 8592922
    [Abstract] [Full Text] [Related]

  • 25. Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value.
    Zambelli S, Zanin A, Gaglio A, Zai G, Bosco E, Andrion A, Magnani C.
    Arch Ital Urol Androl; 1993 Dec; 65(6):665-70. PubMed ID: 8312949
    [Abstract] [Full Text] [Related]

  • 26. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
    Offner FA, Schäfer G, Hittmair A, Ofner D, Grünewald K, Weyrer K, Mattern D, Eberle J, Mikuz G, Feichtinger H.
    Verh Dtsch Ges Pathol; 1993 Dec; 77():241-6. PubMed ID: 7511289
    [Abstract] [Full Text] [Related]

  • 27. Clinical value of argyrophilic organizer region in bladder transitional cell carcinoma.
    Shiina H, Shirakawa H, Yokogi H, Kishi H, Mizutani M, Igawa M, Ishibe T.
    Urol Int; 1995 Dec; 54(2):74-9. PubMed ID: 7747363
    [Abstract] [Full Text] [Related]

  • 28. Cell proliferation in breast tumours: analysis of histological parameters Ki67 and PCNA expression.
    Sullivan RP, Mortimer G, Muircheartaigh IO.
    Ir J Med Sci; 1993 Sep; 162(9):343-7. PubMed ID: 7903289
    [Abstract] [Full Text] [Related]

  • 29. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
    Sun W, Herrera GA.
    Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
    [Abstract] [Full Text] [Related]

  • 30. Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological description.
    Lipponen PK, Eskelinen MJ.
    Anticancer Res; 1992 Oct; 12(2):577-83. PubMed ID: 1349799
    [Abstract] [Full Text] [Related]

  • 31. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
    Chowdhury GM, Kojima K, Kanayama H, Tsuji M, Kurokawa Y, Kagawa S.
    Cancer; 1996 Aug 15; 78(4):827-33. PubMed ID: 8756378
    [Abstract] [Full Text] [Related]

  • 32. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
    Moll R, Achtstätter T, Becht E, Balcarova-Ständer J, Ittensohn M, Franke WW.
    Am J Pathol; 1988 Jul 15; 132(1):123-44. PubMed ID: 2456018
    [Abstract] [Full Text] [Related]

  • 33. [Inverted transitional-cell papilloma: the expression of the Ki-67 nuclear antigen as a prognostic factor].
    Valero Puerta JA, Redondo Martínez E, Jieménez González C, Gómez Medina ML, Martínez de la Riva SI.
    Arch Esp Urol; 1995 Nov 15; 48(9):887-92. PubMed ID: 8554393
    [Abstract] [Full Text] [Related]

  • 34. [Expression of squamous cell carcinoma-associated antigen in bladder cancer cells--a comparative study with the expression of proliferating cell nuclear antigen (PCNA)].
    Yamazaki K, Kumamoto Y, Tsukamoto T.
    Nihon Hinyokika Gakkai Zasshi; 1994 Apr 15; 85(4):589-98. PubMed ID: 7910645
    [Abstract] [Full Text] [Related]

  • 35. Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder.
    Mangrud OM, Gudlaugsson E, Skaland I, Tasdemir I, Dalen I, van Diermen B, Baak JP, Janssen EA.
    Hum Pathol; 2014 Jul 15; 45(7):1496-503. PubMed ID: 24796506
    [Abstract] [Full Text] [Related]

  • 36. MOLECULAR CHARACTERISTICS OF THE HETEROGENEITY OF NON-INVASIVE PAPILLARY UROTHELIAL CARCINOMAS AND THE MARKERS OF THEIR RECURRENCE.
    Kajaia D, Kochiashvili D, Muzashvili T, Gachechiladze M, Burkadze G.
    Georgian Med News; 2021 Jul 15; (316-317):178-184. PubMed ID: 34511468
    [Abstract] [Full Text] [Related]

  • 37. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
    Pich A, Chiusa L, Formiconi A, Galliano D, Bortolin P, Comino A, Navone R.
    Cancer; 2002 Aug 15; 95(4):784-90. PubMed ID: 12209722
    [Abstract] [Full Text] [Related]

  • 38. Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas.
    Izadifar V, de Boer WI, Muscatelli-Groux B, Maillé P, van der Kwast TH, Chopin DK.
    Hum Pathol; 1999 Apr 15; 30(4):372-7. PubMed ID: 10208456
    [Abstract] [Full Text] [Related]

  • 39. [The relationship between the estimated tumor growth speed and indices of bromodeoxyuridine (BrdU) incorporation and the proliferating cell nuclear antigen (PCNA) expression in superficial bladder cancer].
    Ota T, Akaza H, Hattori K, Uchida K.
    Nihon Hinyokika Gakkai Zasshi; 1997 Oct 15; 88(10):868-73. PubMed ID: 9388366
    [Abstract] [Full Text] [Related]

  • 40. Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder.
    Nakagawa T, Kanai Y, Saito Y, Kitamura T, Kakizoe T, Hirohashi S.
    J Urol; 2003 Dec 15; 170(6 Pt 1):2463-6. PubMed ID: 14634451
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.